Astragaloside injection preparation and its preparing process
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of glycoside injection and astragaloside IV, applied in the field of medicine, can solve the problems of poor solubility of astragaloside IV and the like
Inactive Publication Date: 2004-11-10
上海博泰医药科技有限公司
View PDF0 Cites 22 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The present invention studies the solubility of astragaloside IV and solves the problem of poor solubility of astragaloside IV
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Embodiment 1 (small injection);
[0018] Component Quantity (g / bottle)
[0019] Astragaloside IV 0.005
[0020] Ethanol 0.50
[0021] Propylene glycol 0.50
[0022] Glycerin 0.10
[0023] The preparation process is:
[0024] Take astragaloside IV, add ethanol, glycerin and propylene glycol to dissolve, filter and sterilize, subpackage and seal, and sterilize to obtain the product. The content of astragaloside IV in the astragaloside IV raw material is 97% of the labeled amount.
Embodiment 2
[0025] Embodiment 2 (powder injection);
[0026] Component Quantity (g / bottle)
[0027] Astragaloside IV 0.01
[0028] Mannitol 0.03
[0029] The preparation process is:
[0030] Take astragaloside IV, add mannitol, add 20ml of water, heat to dissolve, weigh hot filter to sterilize, sub-package, and freeze-dry to obtain. The content of astragaloside IV in the astragaloside IV raw material is 95% of the labeled amount.
Embodiment 3
[0031] Embodiment 3 (powder injection)
[0032] Component Quantity (g / bottle)
[0033] Astragaloside IV 0.03
[0034] Lactose 0.05
[0035] The preparation process is:
[0036] Take astragaloside IV and lactose, add 10ml of ethanol, dissolve, filter and sterilize, spray dry, aseptically subpackage, and press the cap to get it. The content of astragaloside IV in the astragaloside IV raw material is 100% of the labeled amount.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an astragaloside IV injection preparation (small injection, powder injection, glucose fluid infusion and sodium chloride fluid infusion), and the process for its preparation, wherein the auxiliary solvent and solvent assisting deflocculating agent are screened, which has proved that propylene glycol, ethanol, glycerin, polyethylene glycol, benzyl benzoate and acetic acid dimethylamide has solubilization function for astragaloside IV.
Description
technical field [0001] The invention belongs to the technical field of medicine, in particular to a pharmaceutical preparation of astragaloside IV, more specifically to an injection of astragaloside IV (including small injections, powder injections, glucose infusion and sodium chloride infusion). It relates to a preparation method of the preparation. Background technique [0002] Astragalus is a traditional traditional Chinese medicine that invigorates qi and strengthens the surface, diuretics and toxins, drains pus, and suppresses sores and promotes granulation. A large number of studies have shown that the main active ingredient of astragalus with cardiovascular activity is astragaloside IV. Traditional Chinese medicine believes that qi stagnation and blood stasis are a major cause of cardiovascular and cerebrovascular diseases, and astragaloside IV is effective in treating qi stagnation and blood stasis cardiovascular and cerebrovascular diseases. [0003] At present, m...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more